Novo Nordisk A/S (NVO)
Last Price$101.7(3.4%)
Market Cap$604.5B
NVO overview
Crunching data... Almost there!
1W (5.1%)
1M (13.6%)
6M (24.2%)
YTD 0.4%
1Y 6.3%
3Y 84.2%
5Y 275.8%
10Y 439.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
NVO key stats
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
NVO Intrinsic value
NVO Intrinsic value overview
NVO Historical intrinsic value
NVO Financials
NVO Income statement
Crunching data... Almost there!
NVO Balance sheet
Crunching data... Almost there!
NVO Cash flow statement
Crunching data... Almost there!
NVO Financial ratios
NVO Growth
Crunching data... Almost there!
NVO Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more NVO fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of Novo Nordisk A/S (NVO) stock?
As of today, intrinsic value of Novo Nordisk A/S is $222.9.
Is Novo Nordisk A/S (NVO) stock undervalued or overvalued?
As of today, Novo Nordisk A/S is undervalued by 54.4%, compared to the current market share price of $101.7.
What is Novo Nordisk A/S (NVO) stock rating?
As of today, Novo Nordisk A/S has a stock rating of 8 (out of 10), which is considered Great.
is Novo Nordisk A/S (NVO) a good stock to buy?
As of today, Novo Nordisk A/S has a Great stock rating, which is 54.4% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.